Folate-targeted multifunctional amino acid-chitosan nanoparticles for improved cancer therapy

Pharmaceutical Research

Volumn 32, Issue 2, 2015, Pages 562-577

  Gaspar, Vítor M ^a   Costa, Elisabete C ^a   Queiroz, João A ^a   Pichon, Chantal ^b   Sousa, Fani ^a   Correia, Ilídio J ^a  

^a UNIVERSITY OF BEIRA INTERIOR   (Portugal)

^b UNIVERSITÉ D'ORLÉANS   (France)

Author keywords

2D co cultures; 3D tumor spheroids; Cancer therapy; Gene delivery; Targeted nanoparticles

Indexed keywords

AMINO ACID MODIFIED CHITOSAN NANOPARTICLE; CHITOSAN NANOPARTICLE; FOLATE RECEPTOR; FOLIC ACID; HEMOGLOBIN; MACROGOL; NANOCARRIER; PROTEIN P53; UNCLASSIFIED DRUG; AMINO ACID; ANTINEOPLASTIC AGENT; CHITOSAN; DRUG CARRIER; NANOPARTICLE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER THERAPY; COCULTURE; COMPLEX FORMATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; FLOW CYTOMETRY; GENE DELIVERY SYSTEM; GENE EXPRESSION; HELA CELL LINE; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MONOCULTURE; PRIORITY JOURNAL; TARGET CELL; TUMOR SPHEROID; ZETA POTENTIAL; CHEMISTRY; DRUG DELIVERY SYSTEM; NEOPLASM; PROCEDURES;

AMINO ACIDS; ANTINEOPLASTIC AGENTS; CHITOSAN; COCULTURE TECHNIQUES; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FOLIC ACID; HELA CELLS; HUMANS; NANOPARTICLES; NEOPLASMS;

EID: 84921485287     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-014-1486-0     Document Type: Article

References (47)

1. Zhang X-Q, Xu X, Bertrand N, Pridgen E, Swami A, Farokhzad OC. Interactions of nanomaterials and biological systems: implications to personalized nanomedicine. Adv Drug Deliv Rev. 2012;64:1363-84.
2. Gaspar VM, Correia IJ, Sousa Â, Silva F, Paquete CM, Queiroz JA, et al. Nanoparticle mediated delivery of pure P53 supercoiled plasmid DNA for gene therapy. J Control Release. 2011;156:212-22.
3. Ragelle H, Vandermeulen G, Préat V. Chitosan-based siRNA delivery systems. J Control Release. 2013;172:207-18.
4. Carocho M, Ferreira ICFR. The role of phenolic compounds in the fight against cancer-a review. Anti-Cancer Agents Med Chem (Formerly Current Medicinal Chemistry-Anti-Cancer Agents). 2013;13(1236-58).
5. Cho H, Lai TC, Kwon GS. Poly (ethylene glycol)-block-poly (ε-caprolactone) micelles for combination drug delivery: evaluation of paclitaxel, Cyclopamine and Gossypol in Intraperitoneal Xenograft Models of Ovarian Cancer. J Control Release. 2013;166:1-9.
6. Maeda H. Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects. Bioconjug Chem. 2010;21:797-802.
7. Bergersand G, Benjamin LE. Tumorigenesis and the angiogenic switch. Nat Rev Cancer. 2003;3:401-10.
8. Decuzzi P, Pasqualini R, Arap W, Ferrari M. Intravascular delivery of particulate systems: does geometry really matter? Pharm Res. 2009;26:235-43.
9. van de Ven AL, Kim P, Haley OH, Fakhoury JR, Adriani G, Schmulen J, et al. Rapid tumoritropic accumulation of systemically injected plateloid particles and their biodistribution. J Control Release. 2012;158:148-55.
10. Florence AT. "Targeting" nanoparticles: the constraints of physical laws and physical barriers. J Control Release. 2012;164:115-24.
11. Hollis CP, Weiss HL, Leggas M, Evers BM, Gemeinhart RA, Li T. Biodistribution and bioimaging studies of hybrid paclitaxel nanocrystals: lessons learned of the EPR effect and image-guided drug delivery. J Control Release. 2013;172:12-21.
12. Danhier F, Feron O, Préat V. To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anticancer drug delivery. J Control Release. 2010;148:135-46.
13. Farokhzad OC, Cheng J, Teply BA, Sherifi I, Jon S, Kantoff PW, et al. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc Natl Acad Sci. 2006;103:6315-20.
14. Chen R, Braun GB, Luo X, Sugahara KN, Teesalu T, Ruoslahti E. Application of a proapoptotic peptide to intratumorally spreading cancer therapy. Cancer Res. 2013;73:1352-61.
15. Choe U-J, Rodriguez AR, Lee BS, Knowles SM, Wu AM, Deming TJ, et al. Endocytosis and intracellular trafficking properties of transferrin-conjugated block copolypeptide vesicles. Biomacromolecules. 2013;14:1458-64.
16. Panand J, Feng S-S. Targeting and imaging cancer cells by folate-decorated, quantum dots (QDs)-loaded nanoparticles of biodegradable polymers. Biomaterials. 2009;30:1176-83.
17. Chen C, Ke J, Zhou XE, Yi W, Brunzelle JS, Li J, et al. Structural basis for molecular recognition of folic acid by folate receptors. Nature. 2013;500:486-9.
18. Mi Y, Liu Y, Feng S-S. Formulation of docetaxel by folic acid-conjugated d-α-tocopheryl polyethylene glycol succinate 2000 (Vitamin E TPGS2k) micelles for targeted and synergistic chemotherapy. Biomaterials. 2011;32:4058-66.
19. Garcia-Bennett A, Nees M, Fadeel B. In search of the holy grail: folate-targeted nanoparticles for cancer therapy. Biochem Pharmacol. 2011;81:976-84.
20. Wu M, Gunning W, Ratnam M. Expression of folate receptor type α in relation to cell type, malignancy, and differentiation in ovary, uterus, and cervix. Cancer Epidemiol Biomark Prev. 1999;8:775-82.
21. C. Aranda, K. Urbiola, A. Méndez Ardoy, J.M. García Fernández, C. Ortiz Mellet, and C.T. de Ilarduya. Targeted gene delivery by new folate-polycationic amphiphilic cyclodextrin-DNA nanocomplexes in vitro and in vivo. European Journal of Pharmaceutics and Biopharmaceutics. 2013;85:390-7.
22. Kogure K, Akita H, Yamada Y, Harashima H. Multifunctional envelope-type nano device (MEND) as a non-viral gene delivery system. Adv Drug Deliv Rev. 2008;60:559-71.
23. Gaspar V, Marques J, Sousa F, Louro R, Queiroz J, Correia I. Biofunctionalized nanoparticles with pH-responsive and cell penetrating blocks for gene delivery. Nanotechnology. 2013;24:275101.
24. HogenEschand H, Nikitin AY. Challenges in pre-clinical testing of anti-cancer drugs in cell culture and in animal models. J Control Release. 2012;164:183-6.
25. Costa EC, Gaspar VM, Marques JG, Coutinho P, Correia IJ. Evaluation of nanoparticle uptake in co-culture cancer models. PLoS One. 2013;8:e70072.
26. Mehta G, Hsiao AY, Ingram M, Luker GD, Takayama S. Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy. J Control Release. 2012;164:192-204.
27. H.-l. Ma, Q. Jiang, S. Han, Y. Wu, J. Cui Tomshine, D. Wang, Y. Gan, G. Zou, and X.-J. Liang. Multicellular tumor spheroids as an in vivo-like tumor model for three-dimensional imaging of chemotherapeutic and nano material cellular penetration. Molecular imaging. 2012;11:487-98.
28. Vargo-Gogolaand T, Rosen JM. Modelling breast cancer: one size does not fit all. Nat Rev Cancer. 2007;7:659-72.
29. Yoshii Y, Waki A, Yoshida K, Kakezuka A, Kobayashi M, Namiki H, et al. The use of nanoimprinted scaffolds as 3D culture models to facilitate spontaneous tumor cell migration and well-regulated spheroid formation. Biomaterials. 2011;32:6052-8.
30. Zhang C, Gao S, Jiang W, Lin S, Du F, Li Z, et al. Targeted minicircle DNA delivery using folate-poly(ethylene glycol)-polyethylenimine as non-viral carrier. Biomaterials. 2010;31:6075-86.
31. van Gaal EV, van Eijk R, Oosting RS, Kok RJ, Hennink WE, Crommelin DJ, et al. How to screen non-viral gene delivery systems in vitro? J Control Release. 2011;154:218-32.
32. Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9:676-82.
33. Napolitano AP, Dean DM, Man AJ, Youssef J, Ho DN, Rago AP, et al. Scaffold-free three-dimensional cell culture utilizing micromolded nonadhesive hydrogels. Biotechniques. 2007;43:494-500.
34. Fujiwara Y, Kikuchi H, Aizawa S, Furuta A, Hatanaka Y, Konya C, et al. Direct uptake and degradation of DNA by lysosomes. Autophagy. 2013;9:1167-71.
35. Chang KL, Higuchi Y, Kawakami S, Yamashita F, Hashida M. Development of lysine-histidine dendron modified chitosan for improving transfection efficiency in HEK293 cells. J Control Release. 2011;156:195-202.
36. Ernsting MJ, Murakami M, Roy A, Li S-D. Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles. J Control Release. 2013;172:782-94.
37. Johnson RN, Kopecková P, Kopecek J. Synthesis and evaluation of multivalent branched HPMA copolymer - fab' conjugates targeted to the B-cell antigen CD20. Bioconjug Chem. 2008;20:129-37.
38. Maya S, Kumar LG, Sarmento B, Sanoj Rejinold N, Menon D, Nair SV, et al. Cetuximab conjugated O-carboxymethyl chitosan nanoparticles for targeting EGFR overexpressing cancer cells. Carbohydr Polym. 2013;93:661-9.
39. Ford J. Red blood cell morphology. Int J Lab Hematol. 2013;35:351-7.
40. Ditto AJ, Shah KN, Robishaw NK, Panzner MJ, Youngs WJ, Yun YH. The Interactions between l-tyrosine based nanoparticles decorated with folic acid and cervical cancer cells under physiological flow. Mol Pharm. 2012;9:3089-98.
41. Straussman R, Morikawa T, Shee K, Barzily-Rokni M, Qian ZR, Du J, et al. Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion. Nature. 2012;487:500-4.
42. Delinassiosand J, Kottaridis S. Interactions between human fibroblasts and HeLa cells in vitro. Biol Cell. 1984;50:9-16.
43. Gao Y, Li M, Chen B, Shen Z, Guo P, Wientjes MG, et al. Predictive models of diffusive nanoparticle transport in 3-dimensional tumor cell spheroids. AAPS J. 2013;15:816-31.
44. LaBarbera DV, Reid BG, Yoo BH. The multicellular tumor spheroid model for high-throughput cancer drug discovery. Expert Opin Drug Discov. 2012;7:819-30.
45. Hu Q, Gu G, Liu Z, Jiang M, Kang T, Miao D, et al. F3 peptide-functionalized PEG-PLA nanoparticles co-administrated with tLyp-1 peptide for anti-glioma drug delivery. Biomaterials. 2012;34:1135-45.
46. Kim Y-K, Minai-Tehrani A, Lee J-H, Cho C-S, Cho M-H, Jiang H-L. Therapeutic efficiency of folated poly (ethylene glycol)-chitosan-graft-polyethylenimine-Pdcd4 complexes in H-ras12V mice with liver cancer. Int J Nanomedicine. 2013;8:1489-98.
47. Shen J-M, Guan X-M, Liu X-Y, Lan J-F, Cheng T, Zhang H-X. Luminescent/magnetic hybrid nanoparticles with folate-conjugated peptide composites for tumor-targeted drug delivery. Bioconjug Chem. 2012;23:1010-21.